Status:

COMPLETED

Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients

Lead Sponsor:

Huashan Hospital

Collaborating Sponsors:

Baxter Healthcare Corporation

Conditions:

Peritoneal Dialysis

Pioglitazone

Eligibility:

All Genders

Phase:

NA

Brief Summary

1. Background:Cardiovascular disease (CVD) is the major cause of mortality in peritoneal dialysis (PD) patients, in whom it is partly attributable to a higher prevalence of dysmetabolism. Currently, f...

Detailed Description

Cardiovascular disease (CVD) is the major cause of mortality in chronic kidney disease, including peritoneal dialysis (PD) patients. While survival has not been shown to differ between peritoneal and ...

Eligibility Criteria

Inclusion

  • All patients received more than one month regular continuous ambulatory peritoneal dialysis(CAPD) or intermittent peritoneal dialysis(IPD). The causes of chronic renal failure were diabetes and non-diabetes.-

Exclusion

  • history of allergy to thiazolidinediones and fenofibrate; history of any sever adverse event for fibrate that can't be tolerated by the patients; patient can not be follow-up regularly; history of myocardial infarction(MI) or coronary artery bypass graft (CABG) surgery within the past 1 month, history of cerebral vascular accident (CVA) or percutaneous transluminal coronary angioplasty(PTCA) within the past 6 months; chronic use of non-steroidal anti-inflammatory drugs(NSAIDs), steroids or immunosuppressives; patient with the acute infection; patient with malignant tumor; have the evidence of severe hepatic injury (ALT/AST\>100u/L).-

Key Trial Info

Start Date :

January 1 2008

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

September 1 2008

Estimated Enrollment :

70 Patients enrolled

Trial Details

Trial ID

NCT01258322

Start Date

January 1 2008

End Date

September 1 2008

Last Update

December 10 2010

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Pioglitazone Attenuates Dysmetabolism in Peritoneal Dialysis (PD) Patients | DecenTrialz